Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe
Autor
Jones, Allan
Bardramb, Jakob Eyvind
Bækgaardb, Per
Cramer-Petersenb, Claus Lundgaard
Skinner, Timothy
Vrangbækc, Karsten
Starr, Laila
Nørgaardd, Kirsten
Lindd, Nanna
Christensend, Merete Bechmann
Glümer, Charlotte
Wang-Sattler, Rui
Laxyf, Michael
Brander, Erik
Heinemanni, Lutz
Heisei, Tim
Schliess, Freimut
Ladewigj, Katharina
Kownatkaa, Dagmar
Institución
Resumen
Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike.
Building on an iterative six-step disease management process that leverages feedback loops and utilizes
commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized
diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a
sustainable way. The novel “iPDM Goes Europe” consortium strives to advance iPDM adoption by (1)
implementing the concept in a value-based healthcare setting for the treatment of persons living with
type 2 diabetes, (2) providing tools to assess the patient’s physical and mental health status, and (3)
exploring new avenues to take advantage of emerging big data resources.